| 产品详情 |
| Edit |   |
|---|
| Product Name | CD2665 |
|---|
| Description | Purity >98%. CD2665 is a selective retinoic acid receptor (RAR)Beta and RARGamma antagonist (Kd s = 110, 306, and > 2,250 nM for RARGamma, RARBeta, and RARAlpha, respectively, with no binding at RXRAlpha). At 10-7 M, it has been used to abrogate retinoic acid -induced antiproliferative and antidifferentiative effects on sebocyte growth. This compound has been used in animal and in vitro cell models to explore the role of retinoid signaling in a number of biological processes including memory formation and tumor proliferation. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[6-[(2-methoxyethoxy)methoxy]-7-tricyclo[3.3.1.13,7 ]dec-1-yl-2-naphthalenyl]-benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 170355-78-9 |
|---|
| Catalog # | LS-H7037 |
|---|
| Price | |
|---|
| Order / More Info | CD2665 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|